Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-30

Clinical Trial Update: NEWPROMRI-PATHWAY - A New Prostate Magnetic Resonance Imaging (MRI) Pathway

View source ↗

Summary

This entry describes the NEWPROMRI-PATHWAY trial, evaluating a new MRI-based pathway for prostate cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospitals of North Midlands NHS Trust | Conditions: Prostate Cancer, MRI | Status: RECRUITING